Abstract
Sedative agents are used to facilitate sexual assault due to their ability to render the victim passive, submissive and unable to resist. The primary pharmacological effect of the benzodiazepine tetrazepam is muscle relaxation, whereas the benzodiazepine diazepam acts on the central nervous system (CNS) exerting mainly sedation effects. Therefore, contrary to tetrazepam, diazepam is an often-abused drug, which can potentially be used as a date-rape drug. In this study, we describe the detection of low amounts of diazepam in Myolastan® (Sanofi–Synthelabo S.A., Brussels, Belgium) and Epsipam® (Will-Pharma, Wavre, Belgium) 50mg tablet preparations by LC-MS-MS, GC-FID and HPLC-DAD. Considering the important forensic implication of this finding, a study was conducted with volunteers receiving a single or repeated dosage of Myolastan®. Urine, hair and preserved oral fluid samples were analysed using a previously described sensitive and specific LC-MS-MS detection method allowing for the simultaneous quantification of tetrazepam, diazepam, nordiazepam, oxazepam and temazepam. This study demonstrates that diazepam can be observed in urine samples even after a single dose of Myolastan®. In addition, maintaining therapy for 1 week results in the detection of both diazepam and nordiazepam in urine samples and of diazepam in the first hair segment. Importantly, comparing urine and hair samples after a single intake of diazepam versus the single and 1 week administration of Myolastan® shows that the possible metabolic conversion of tetrazepam to diazepam is a more plausible explanation for the detection of diazepam in biological samples after the intake of Myolastan®. As such, these results reveal that the presence of diazepam and/or nordiazepam in biological samples from alleged drug-facilitated assault cases should be interpreted with care.



Similar content being viewed by others
References
Cheze M, Villain M, Pepin G (2004) Forensic Sci Int 145:123–130
ElSohly MA, Gul W, ElSohly KM, Avula B, Khan IA (2006) J Anal Toxicol 30:524–538
Hurley M, Parker H, Wells DL (2006) J Clin Forensic Med 13:181–185
Kintz P, Villain M, Dumestre-Toulet V, Ludes B (2005) J Clin Forensic Med 12:36–41
Ohshima T (2006) J Clin Forensic Med 13:44–45
Scott-Ham M, Burton FC (2006) J Clin Forensic Med 13:107–111
Villain M, Cheze M, Dumestre V, Ludes B, Kintz P (2004) J Anal Toxicol 28:516–519
Villain M, Cheze M, Tracqui A, Ludes B, Kintz P (2004) Forensic Sci Int 143:157–161
Negrusz A, Gaensslen RE (2003) Anal Bioanal Chem 376:1192–1197
Scott-Ham M, Burton FC (2005) J Clin Forensic Med 12:175–186
Kintz P, Villain M, Cheze M, Pepin G (2005) Forensic Sci Int 153:222–226
Kintz P, Villain M, Dumestre-Toulet V, Capolaghi B, Cirimele V (2005) Ther Drug Monit 27:741–743
Laloup M, Ramirez Fernandez MM, De Boeck G, Wood M, Maes V, Samyn N (2005) J Anal Toxicol 29:616–626
Kintz P, Villain M, Ludes B (2004) Ther Drug Monit 26:211–214
Concheiro M, Villain M, Bouchet S, Ludes B, Lopez-Rivadulla M, Kintz P (2005) Ther Drug Monit 27:565–570
Kintz P, Villain M, Cirimele V, Pepin G, Ludes B (2004) Forensic Sci Int 145:131–135
Kintz P, Villain M, Ludes B (2004) J Chromatogr B Anal Technol Biomed Life Sci 811:59–63
Samyn N, Verstraete A, van Haeren C, Kintz P (1999) Forensic Sci Rev 11:1–19
Cone EJ, Presley L, Lehrer M, Seiter W, Smith M, Kardos KW, Fritch D, Salamone S, Niedbala RS (2002) J Anal Toxicol 26:541–546
Shah VP, Midha KK, Dighe S, McGilveray IJ, Skelly JP, Yacobi A, Layloff T, Viswanathan CT, Cook CE (1991) Eur J Drug Metab Pharmacokinet 16:249–255
Shah VP, Midha KK, Findlay JW, Hill HM, Hulse JD, McGilveray IJ, McKay G, Miller KJ, Patnaik RN, Powell ML, Tonelli A, Viswanathan CT, Yacobi A (2000) Pharm Res 17:1551–1557
Herzler M, Herre S, Pragst F (2003) J Anal Toxicol 27:233–242
Kintz P, Villain M, Concheiro M, Cirimele V (2005) Forensic Sci Int 150:213–220
Quintela O, Cruz A, Castro A, Concheiro M, Lopez-Rivadulla M (2005) J Chromatogr B Anal Technol Biomed Life Sci 825:63–71
Bonfiglio R, King RC, Olah TV, Merkle K (1999) Rapid Commun Mass Spectrom 13:1175–1185
Moffat AC, Osselton MD, Widdop B (2004) (eds) Clarke’s analysis of drugs and poisons. Phramaceutical Press, London
Sharp ME, Wallace SM, Hindmarsh KW, Peel HW (1983) J Anal Toxicol 7:11–14
Henderson GL, Harkey MR, Zhou C, Jones RT, Jacob P III (1996) J Anal Toxicol 20:1–12
Maurer H, Pfleger K (1987) J Chromatogr 422:85–101
Pavlic M, Libiseller K, Grubwieser P, Schubert H, Rabl W (2006) Int J Legal Med (in press)
Acknowledgements
The authors would like to thank Dr. Frank Peters and Dr. Jochen Beyer for their valuable discussions and suggestions.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Laloup, M., Ramirez Fernandez, M.d.M., Wood, M. et al. Detection of diazepam in urine, hair and preserved oral fluid samples with LC-MS-MS after single and repeated administration of Myolastan® and Valium®. Anal Bioanal Chem 388, 1545–1556 (2007). https://doi.org/10.1007/s00216-007-1297-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-007-1297-9


